Read our latest news, and find more about us and our portfolio companies.

Concerto Biosciences Raises $23 Million in Series A

Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline With funding round by M Ventures, Safar Partners and Horizons Ventures Concerto progresses vision to reinvent humanity’s relationship with microbes

M Ventures leads oversubscribed £37.5 million Series A financing of Nucleome Therapeutics

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines • Financing led by M Ventures alongside other new investors JJDC, Pfizer Ventures and British Patient Capital, and including founding investor Oxford Science Enterprises • Nucleome’s pioneering platform seeks to identify direct genetic linkages to disease-associated genes for drug discovery • Funds will advance Nucleome’s autoimmune disease programmes and fuel expansion of its dark genome atlas

Future Fertility's AI-powered oocyte-assessment tools receive CE Mark

Future Fertility's AI-powered oocyte-assessment tools receive CE Mark under the new European Union Medical Device Regulation (MDR)

Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022

Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022

STORM Therapeutics Appoints New CEO

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer

Akili is now listed on Nasdaq

Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I

Plexium Appoints Brian Wong To Its Board of Directors

Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Brian Wong as a member of its Board of Directors.

M Ventures Invests in TIGNIS for Sustainability in Semiconductor Mfg. in Series A

Tignis, a technology innovator in AI process control for semiconductor manufacturing, today announced it has received Series A funding from M Ventures, the strategic corporate venture arm of Merck, KGaA, Darmstadt, Germany—a leading science and technology company. This investment brings Tignis’ total Series A funding received in 2022 to $10 million. Tignis was introduced to M Ventures through the SEMI Startups for Semiconductor Sustainability program.

Metalenz and STMicroelectronics Deliver World’s First Optical Metasurface Technology for Consumer Electronics Devices

Metalenz metasurfaces are now on the market through its partnership with STMicroelectronics, marking the introduction of this revolutionary optical technology in real-world devices

Scipio bioscience selected for €2.5M European Innovation Council grant

Scipio bioscience has been selected by the @European Innovation Council for a €2.5M grant to pursue their efforts toward the next generation of single-cell tools

Asceneuron Awarded Second Grant from The Michael J. Fox Foundation

Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson’s Disease Therapies

Future Fertility Announces New CEO

Future Fertility today announced that Christine Prada has been named as Chief Executive Officer. Her employment with Future Fertility will commence in early May.

Electroninks Announces Production-Scale Availability of Full Suite of Metal Complex Conductive Ink Solutions

Electroninks, Inc., today announced the production-scale availability of its full suite of proprietary metal organic decomposition (MOD) conductive metal ink solutions. In addition to bringing standalone ink products to market, Electroninks is also bringing total solutions to the customer with its line of ink products, including its own small (desktop) prototype additive manufacturing solution for rapid on-demand printed circuit board (PCB) printing and repair, called CircuitJet.

SynSense steps into the field of smart cockpits by initiating a technological exploration with BMW

SynSense, announced that it will advance the integration of neuromorphic chips and smart cockpits and explore related fields with BMW. This marks the entry point for the application of SynSense’s brain-like technology into smart cockpits

DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology

Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin

iOnctura data at AACR demonstrates unique mechanism of action for clinical stage autotaxin inhibitor IOA-289

iOnctura has preclinical data that shows its autotaxin inhibitor IOA-289 both inhibits pancreatic cells directly and inhibits the cancerpromoting activity of secreted factors from Cancer-Associated Fibroblasts (CAFS)

DNA Script Partners with Asia-Pacific Distributors as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis

DNA Script expands worldwide footprint to China, Hong Kong, India, Singapore, South Korea and Taiwan for sales, distribution, and support of enzymatic synthesis products

Asceneuron Publishes Preclinical Efficacy Data on ASN90

Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer’s and Parkinson’s Disease Models

Cybernews Interview with Metalenz Co-Founder and CEO Rob Devlin

Since the pandemic caused a digital transformation for many companies and locked everyone at home, the need for technology suitable to use from home has only increased

Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform

Altoida, Inc. raised an additional $14 million for its Series A round with new and existing investors. The investment was co-led by M Ventures and Whitecap Venture Partners

Dr Marie McAvoy joins NanoSyrinx as Chief Scientific Officer

NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer

iOnctura To Present Preclinical Data On Its Clinical Stage Autotaxin Inhibitor, IOA-289, At AACR

iOnctura SA will present preclinical data on its next-generation autotaxin inhibitor, IOA-289, at the annual meeting of the American Association for Cancer Research (AACR) taking place on April 8-13, 2022 in New Orleans, Louisiana.

DNA Script Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022

DNA Script’s enzymatic DNA printing on demand technology recognized as no. 3 in the biotech category

Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

Maker of the first-and-only FDA-cleared prescription video game treatment joins the ranks of Canva, Microsoft, SpaceX, and more

NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets

NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets - NEC OncoImmunity to initiate first clinical trial with lead program from acquisition in 2022

DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies

Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era in healthcare

Scipio bioscience launches commercialization in Europe of Asteria, its RNA sequencing kit

Scipio bioscience announces the launch in Europe of Asteria©, its innovative kit for sequencing RNA on individual cells on lab benchtops

Celestial AI Raises $56 Million Series A to Disrupt the Artificial Intelligence Chipset Industry with Novel Photonic-Electronic Technology Platform

Celestial AI’s system transforms computing using light for data movement within and between chips enabling scalability with optical access to memory and compute from single node to exascale systems

Metalenz Launches Gemini to Make 3D Sensing Easier with Selectable Illuminator Optics

Metalenz Inc. today unveiled the GeminiTM product family, switchable illumination optics based on foundational polarization IP

Akili to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Future Fertility Raises Series A to Progress First-In-Class AI-Enabled Fertility Solutions to Improve IVF Outcomes

First company to develop an AI product to predict egg viability with potential to significantly improve IVF outcomes Financing led by M Ventures with participation from Whitecap Venture Partners